Fate Therapeutics Inc
FATE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001434316
In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 2 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $193.2M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Fate Therapeutics Inc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 143 | 1 | 146 | +4 |
| Shares | 80.6M | 11.6K | 72.1M | −8.44M (−10.5%) |
| Value | $101.6M | $14.6K | $70.9M | −$30.6M (−30.2%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Fate Therapeutics Inc at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 1,527,986 | $1.50M | 0.00% |
| DAFNA Capital Management LLC | 550,000 | $540.4K | 0.13% |
| Connor, Clark & Lunn Investment Management Ltd. | 111,227 | $109.3K | 0.00% |
| State of Tennessee, Treasury Department | 90,000 | $107.1K | 0.00% |
| Shay Capital LLC | 70,000 | $68.8K | 0.01% |
| Virtu Financial LLC | 68,871 | $68.0K | 0.00% |
| Manufacturers Life Insurance Company, The | 35,658 | $35.0K | 0.00% |
| CI Private Wealth, LLC | 29,830 | $29.3K | 0.00% |
| Commonwealth Equity Services, LLC | 26,548 | $26.1K | 0.00% |
| Bronte Capital Management Pty Ltd. | 22,853 | $22.5K | 0.00% |
| Nine Masts Capital Ltd | 19,445 | $19.1K | 0.00% |
| Sagewood Asset Management LP | 15,003 | $14.7K | 0.01% |
| Neuberger Berman Group LLC | 13,950 | $13.7K | 0.00% |
| AlphaCore Capital LLC | 12,689 | $12.5K | 0.00% |
| Northern Lights Advisors, Inc. | 10,040 | $9.87K | 0.01% |
| Simplex Trading, LLC | 1,629 | $1.60K | 0.00% |
| Fortitude Family Office, LLC | 520 | $511 | 0.00% |
| GAMMA Investing LLC | 222 | $218 | 0.00% |
| Farther Finance Advisors, LLC | 100 | $98 | 0.00% |
| Sunbelt Securities, Inc. | 30 | $29 | 0.00% |
| Rothschild Investment LLC | 27 | $27 | 0.00% |
Sold out (17)
Institutions that held Fate Therapeutics Inc at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Wilshire Advisors LLC | 8,486,822 | $10.7M |
| Jacobs Levy Equity Management, Inc | 814,639 | $1.03M |
| Ameriprise Financial Inc | 261,671 | $329.7K |
| Public Employees Retirement System of Ohio | 113,655 | $143.2K |
| Atom Investors LP | 110,231 | $138.9K |
| Algert Global LLC | 106,920 | $134.7K |
| Torrey Growth & Income Advisors | 67,522 | $85.1K |
| China Universal Asset Management Co., Ltd. | 20,216 | $25.5K |
| Titleist Asset Management, LLC | 19,000 | $23.9K |
| Squarepoint Ops LLC | 15,554 | $19.6K |
| Osborne Partners Capital Management, LLC | 10,000 | $12.6K |
| SRS Capital Advisors, Inc. | 8,570 | $10.8K |
| Mirae Asset Global Investments Co., Ltd. | 4,459 | $5.62K |
| CX Institutional | 2,817 | $4.00K |
| GF Fund Management Co. Ltd. | 2,396 | $3.02K |
| Rise Advisors, LLC | 633 | $798 |
| Cloud Capital Management, LLC | 32 | $0 |
Not filed for Q4 2025 yet (1)
Institutions that held Fate Therapeutics Inc at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| CIBC Bancorp USA Inc. | 11,593 | $14.6K |